Global Etoricoxib Tablet Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Etoricoxib Tablet Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Etoricoxib is used to reduce inflammation (swelling) and relieve pain in arthritic conditions such as osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
Etoricoxib Tablet report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Etoricoxib Tablet market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Osteoarthritis (OA) and Rheumatoid Arthritis (RA) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Etoricoxib Tablet industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Etoricoxib Tablet key manufacturers include Merk, AdvaCare, Alpha Drugs, BSA Pharma Inc., Vibcare Pharma Pvt Ltd, WELLONA PHARMA, Incepta Pharmaceuticals Ltd., LXIR Medilabs and Swissche Healthcare, etc. Merk, AdvaCare, Alpha Drugs are top 3 players and held % sales share in total in 2022.
Etoricoxib Tablet can be divided into 60mg, 90mg and 120mg,, etc. 60mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Etoricoxib Tablet is widely used in various fields, such as Osteoarthritis (OA), Rheumatoid Arthritis (RA), Ankylosing Spondylitis and Others, etc. Osteoarthritis (OA) provides greatest supports to the Etoricoxib Tablet industry development. In 2022, global % sales of Etoricoxib Tablet went into Osteoarthritis (OA) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Etoricoxib Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merk
AdvaCare
Alpha Drugs
BSA Pharma Inc.
Vibcare Pharma Pvt Ltd
WELLONA PHARMA
Incepta Pharmaceuticals Ltd.
LXIR Medilabs
Swissche Healthcare
MK Medicine
QILU PHARMACEUTICAL CO.,LTD
Segment by Type
60mg
90mg
120mg
Osteoarthritis (OA)
Rheumatoid Arthritis (RA)
Ankylosing Spondylitis
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Etoricoxib Tablet market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Etoricoxib Tablet, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Etoricoxib Tablet industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Etoricoxib Tablet in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Etoricoxib Tablet introduction, etc. Etoricoxib Tablet Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Etoricoxib Tablet market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Etoricoxib Tablet report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Etoricoxib Tablet market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Osteoarthritis (OA) and Rheumatoid Arthritis (RA) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Etoricoxib Tablet industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Etoricoxib Tablet key manufacturers include Merk, AdvaCare, Alpha Drugs, BSA Pharma Inc., Vibcare Pharma Pvt Ltd, WELLONA PHARMA, Incepta Pharmaceuticals Ltd., LXIR Medilabs and Swissche Healthcare, etc. Merk, AdvaCare, Alpha Drugs are top 3 players and held % sales share in total in 2022.
Etoricoxib Tablet can be divided into 60mg, 90mg and 120mg,, etc. 60mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Etoricoxib Tablet is widely used in various fields, such as Osteoarthritis (OA), Rheumatoid Arthritis (RA), Ankylosing Spondylitis and Others, etc. Osteoarthritis (OA) provides greatest supports to the Etoricoxib Tablet industry development. In 2022, global % sales of Etoricoxib Tablet went into Osteoarthritis (OA) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Etoricoxib Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merk
AdvaCare
Alpha Drugs
BSA Pharma Inc.
Vibcare Pharma Pvt Ltd
WELLONA PHARMA
Incepta Pharmaceuticals Ltd.
LXIR Medilabs
Swissche Healthcare
MK Medicine
QILU PHARMACEUTICAL CO.,LTD
Segment by Type
60mg
90mg
120mg
Segment by Application
Osteoarthritis (OA)
Rheumatoid Arthritis (RA)
Ankylosing Spondylitis
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Etoricoxib Tablet market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Etoricoxib Tablet, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Etoricoxib Tablet industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Etoricoxib Tablet in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Etoricoxib Tablet introduction, etc. Etoricoxib Tablet Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Etoricoxib Tablet market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices